VPS35 and Parkinson disease: Here, we comprehensively explore the pathogenic effects of PD-linked VPS35 mutations by exploiting numerous model systems, including Saccharomyces cerevisiae, patient-derived fibroblasts, primary neuronal cultures and viral-mediated gene transfer in rodents.